These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11173005)

  • 1. Heterogeneity in genetic susceptibility to prostate cancer.
    Cussenot O; Valeri A
    Eur J Intern Med; 2001 Feb; 12(1):11-16. PubMed ID: 11173005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary prostate cancer and other genetic predispositions to prostate cancer.
    Cussenot O; Valeri A; Berthon P; Fournier G; Mangin P
    Urol Int; 1998; 60 Suppl 2():30-4; discussion 35. PubMed ID: 9607556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.
    Nwosu V; Carpten J; Trent JM; Sheridan R
    Hum Mol Genet; 2001 Oct; 10(20):2313-8. PubMed ID: 11673416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
    Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
    Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
    Brown WM; Lange EM; Chen H; Zheng SL; Chang B; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cooney KA
    Br J Cancer; 2004 Jan; 90(2):510-4. PubMed ID: 14735201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic susceptibility to prostate cancer].
    Cussenot O; Cancel-Tassin G
    Med Sci (Paris); 2004 May; 20(5):562-8. PubMed ID: 15190476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary prostate cancer].
    Heise M; Haus O
    Postepy Hig Med Dosw (Online); 2014 May; 68():653-65. PubMed ID: 24864115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer genetics.
    Cancel-Tassin G; Cussenot O
    Minerva Urol Nefrol; 2005 Dec; 57(4):289-300. PubMed ID: 16247350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage of prostate cancer susceptibility loci to chromosome 1.
    Xu J; Zheng SL; Chang B; Smith JR; Carpten JD; Stine OC; Isaacs SD; Wiley KE; Henning L; Ewing C; Bujnovszky P; Bleeker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Hum Genet; 2001 Apr; 108(4):335-45. PubMed ID: 11379880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic, epidemiologic and clinical study of familial prostate cancer].
    Valéri A
    Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex genetic epidemiology of prostate cancer.
    Schaid DJ
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R103-21. PubMed ID: 14749351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
    Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
    Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer.
    Bergthorsson JT; Johannesdottir G; Arason A; Benediktsdottir KR; Agnarsson BA; Bailey-Wilson JE; Gillanders E; Smith J; Trent J; Barkardottir RB
    Hum Genet; 2000 Oct; 107(4):372-5. PubMed ID: 11129338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.
    Valeri A; Briollais L; Azzouzi R; Fournier G; Mangin P; Berthon P; Cussenot O; Demenais F
    Ann Hum Genet; 2003 Mar; 67(Pt 2):125-37. PubMed ID: 12675688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective: prostate cancer susceptibility genes.
    Simard J; Dumont M; Soucy P; Labrie F
    Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial prostate carcinoma in Germany].
    Paiss T; Herkommer K; Chab A; Häussler J; Vogel W; Gschwend JE; Hautmann RE
    Urologe A; 2002 Jan; 41(1):38-43. PubMed ID: 11963773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
    Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
    Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.